Identification of novel SSX1 fusions in synovial sarcoma-Reference-Cited by-同舟云学术

Identification of novel SSX1 fusions in synovial sarcoma

Published:2021-09-09 Issue:2 Volume:35 Page:228-239
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Yoshida Akihiko^ORCID,Arai Yasuhito^ORCID,Satomi Kaishi^ORCID,Kubo Takashi,Ryo Eijitsu,Matsushita Yuko,Hama Natsuko,Sudo Kazuki,Komiyama Motokiyo,Yatabe Yasushi^ORCID,Shibata Tatsuhiro,Ichikawa Hitoshi^ORCID,Ichimura Koichi^ORCID,Kawai Akira,Mori Taisuke^ORCID

Funder

MEXT | Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

https://www.nature.com/articles/s41379-021-00910-x.pdf

Reference45 articles.

1. Terry, J. et al. TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am. J. Surg. Pathol. 31, 240–246 (2007).

2. Pelmus, M. et al. Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases. Am. J. Surg. Pathol. 26, 1434–1440 (2002).

3. Kao, Y. C. et al. BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion-A pathologic and molecular pitfall. Genes Chromosomes Cancer 56, 296–302 (2017).